Where's it on?
FDA · Drugs ·

Carbamazepine Tablets recall

Golden State Medical Supply Inc. recalled Carbamazepine Tablets on August 26, 2026 because of cGMP deviations: tablets with black specks. It was sold nationwide.

Why it was recalled

CGMP deviations: tablets with black specks.

What's recalled

Carbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count bottles (NDC 51407-215-01), Rx Only, Manufactured by: Taro Pharmaceutical Industries Ltd., Marketed by: GSMS, Incorporated, Camarillo, CA 93012 USA

Quantity: 1200 bottles

What to do

Check whether you have the product (match the lot numbers, dates or codes in the official notice). Stop using it, and return it or throw it away as the notice says.

Read the official FDA notice